This Award Notice opportunity from Texas was posted on September 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Gene infusions therapy
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The University of Texas Medical Branch at Galveston has entered into a contract with Cura Script Specialty Distribution for the procurement of Zolgensma gene infusions therapy. This award, identified by solicitation number UCLIN-0000620304, is valued at 2,086,043.18 dollars. The contract term is established from July 22, 2025, through July 21, 2027, with a response deadline noted for August 31, 2027. The procurement is classified under NAICS code 424210 and has been certified for compliance by executive leadership. A critical component of this agreement is the risk assessment, which identifies Cura Script Specialty Distribution as the sole approved distributor for this specific gene therapy treatment. This contract was formally reported to the Legislative Budget Board to ensure transparency and adherence to state procurement standards.
General Info
Contract Value
$2,086,043Place of Performance
Not specifiedSet-Aside
Award Issued Date
Documents
1AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
